← Scoopfeeds — Intelligent news, curated.
AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point
business

AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point

Yahoo Finance · Jun 2, 2026, 2:14 PM · Also reported by 1 other source

AstraZeneca’s (AZN) CARES Phase III Clinical Programme Fails to Meet Primary End Point

Read full story on Yahoo Finance → More top stories

Also covered by

Investing.com Praxis reports phase 2/3 epilepsy trial missed primary endpoint

More in business

Investing.com
Iconic Labs converts note into 458,716 shares at £0.0109
Investing.com
Landstar System stock hits all-time high at 215.1 USD
Investing.com
Guggenheim raises Madison Square Garden Sports stock price target on playoff revenue
Investing.com
Exclusive-SpaceX targets $1.75 trillion valuation including greenshoe option in record IPO, sources say
Investing.com
White House Correspondents’ Association dinner to be held on July 24
Aggregated and edited by the Scoop newsroom. We surface news from Yahoo Finance alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop